You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Infections
  5. Hepatitis

Peginterferon alfa and ribavirin for the treatment of chronic hepatitis C

  • Technology appraisal guidance
  • Reference number: TA200
  • Published:  22 September 2010
  • Guidance
  • Tools and resources
  • Information for the public
  • History

TA200 Hepatitis C - peginterferon alfa and ribavirin: Appendix A - decision paper presented to the Institute's Guidance Executive

TA200 Hepatitis C - peginterferon alfa and ribavirin: Appendix A - decision paper presented to the Institute's Guidance Executive TA200 Hepatitis C - peginterferon alfa and ribavirin: Appendix A - decision paper presented to the Institute's Guidance Executive
20 December 2013
(111.64 Kb 32 sec)

Adobe Acrobat reader required.

  Adobe Acrobat reader required.

This page was last updated: 18 December 2013

Back to top